Showing results (61-70 of 139) with videos related to

Sort By:
Pageof 14
Journal of the American Chemical Society|September 3, 2024
Converting the Amyloidogenic Islet Amyloid Polypeptide into a Potent Nonaggregating Peptide Ligand by Side Chain-to-Side Chain MacrocyclizationMargaryta Babych, Michael L Garelja, Phuong Trang Nguyen, et al.
Advances in Experimental Medicine and Biology|March 22, 2012
RAMPs as drug targetsPatrick M Sexton, David R Poyner, John Simms, et al.
British Journal of Pharmacology|December 7, 2011
The third extracellular loop of the human calcitonin receptor-like receptor is crucial for the activation of adrenomedullin signallingKenji Kuwasako, Debbie L Hay, Sayaka Nagata, et al.
Current Opinion in Neurology|June 8, 2022
Is calcitonin gene-related peptide a reliable biochemical marker of migraine?Betel Tesfay, William Kristian Karlsson, Rogelio Dominguez Moreno, et al.
British Journal of Pharmacology|January 18, 2006
Differential activation of G-proteins by mu-opioid receptor agonistsZuzana Saidak, Katherine Blake-Palmer, Debbie L Hay, et al.
Pharmacological Reviews|June 14, 2015
Amylin: Pharmacology, Physiology, and Clinical PotentialDebbie L Hay, Steve Chen, Thomas A Lutz, et al.
British Journal of Pharmacology|November 29, 2012
Structure-activity relationships for α-calcitonin gene-related peptideHarriet A Watkins, Dan L Rathbone, James Barwell, et al.
Pharmacological Reviews|February 9, 2023
Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying ProteinsIlana B Kotliar, Emily Lorenzen, Jochen M Schwenk, et al.
Frontiers in Pharmacology|October 28, 2024
Tirzepatide, GIP(1-42) and GIP(1-30) display unique signaling profiles at two common GIP receptor variants, E354 and Q354Tayla A Rees, Benjamin J Buttle, Zoe Tasma, et al.
Neurology and Therapy|June 2, 2021
Hypervigilance, Allostatic Load, and Migraine Prevention: Antibodies to CGRP or ReceptorAndrew Blumenfeld, Paul L Durham, Alexander Feoktistov, et al.
Pageof 14